Why is Shree Ganesh Bio falling/rising?

As of 15-Jul, Shree Ganesh Biotech India Ltd is currently priced at Rs 0.83, showing no change (0.00%). The stock has underperformed its sector by 1.92% today and is trading below all its moving averages, indicating a bearish trend. Over the past week, the stock has declined by 3.49%, and it has experienced significant losses over longer periods, with a year-to-date decline of 20.19% and a staggering 62.27% drop over three years. The company is facing operational challenges, evidenced by a negative EBITDA and weak long-term fundamental strength, including an average Return on Equity of just 2.60%. Furthermore, the company reported a substantial decline in profits, with a PAT of Rs -0.95 crore, which has fallen by 275.9%.
In the broader market context, the Sensex has shown a slight increase of 1.79% over the past month, contrasting sharply with Shree Ganesh Biotech's 4.60% decline during the same period. This disparity highlights the stock's underperformance relative to the market. While there has been a rise in investor participation, as indicated by a 110.46% increase in delivery volume, the overall sentiment remains negative due to the company's financial struggles and inability to service its debt effectively. The stock's liquidity is adequate for trading, but the prevailing risks and operational losses suggest that investors are cautious, contributing to the stock's ongoing decline.